secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001493152-25-015784
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio gets Nasdaq deficiency notice; must regain $1.00 bid by March 2026
------------------------------------------------------------------------------

- Received letter on September 23, 2025 from Nasdaq Staff for non-compliance with $1.00 minimum bid price rule.
- Common stock closing bid below $1.00 for 30 consecutive business days; no immediate impact on listing.
- Has 180 days (until March 23, 2026) to regain compliance by closing at $1.00+ for at least 10 consecutive days.
- If not cured, may transfer to Nasdaq Capital Market for an additional 180-day compliance period.
- Company will monitor bid price and evaluate options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315225015784/0001493152-25-015784-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315225015784/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-015784

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer